---
title: "GLORIA PHARMA: Injectable multiple vitamins pass consistency evaluation"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/245860215.md"
description: "GLORIA PHARMA announced that its wholly-owned subsidiary, Pude Pharmaceutical, has received the Drug Supplement Application Approval Notice issued by the National Medical Products Administration for injectable multivitamins. This drug has passed the consistency evaluation of the quality and efficacy of generic drugs. Injectable multivitamins are suitable for adult patients and children over 11 years old, with sales expected to reach RMB 1.916 billion in urban public hospitals and county-level public medical institutions in China in 2024. Pude Pharmaceutical has invested approximately RMB 3.6706 million in the consistency evaluation work for this drug"
datetime: "2025-06-24T09:34:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/245860215.md)
  - [en](https://longbridge.com/en/news/245860215.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/245860215.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/245860215.md) | [繁體中文](https://longbridge.com/zh-HK/news/245860215.md)


# GLORIA PHARMA: Injectable multiple vitamins pass consistency evaluation

GLORIA PHARMA announced that its wholly-owned subsidiary, Pude Pharmaceutical, has received the approval notice for the supplementary application of injectable multivitamins issued by the National Medical Products Administration. This drug has passed the consistency evaluation of quality and efficacy for generic drugs. Injectable multivitamins are suitable for adult patients and children over 11 years old, with sales expected to reach 1.916 billion yuan in urban public hospitals and county-level public medical institutions in China in 2024. Pude Pharmaceutical has invested approximately 3.6706 million yuan in the consistency evaluation work for this drug

### Related Stocks

- [GLORIA PHARMA. (002437.CN)](https://longbridge.com/en/quote/002437.CN.md)

## Related News & Research

- [Rising Stars: Chris Kraemer on the power of patient impact](https://longbridge.com/en/news/277767990.md)
- [13:50 ETNejvětší farmaceutický veletrh v Asii se v červnu 2026 vrátí do Šanghaje](https://longbridge.com/en/news/277666717.md)
- [LESS NOISE, BETTER SIGNALS: HOW PHARMA CAN MEASURE IMPACT AS AI RESHAPES SEARCH](https://longbridge.com/en/news/277470520.md)
- ['Jurassic Park' paleontologist to leave university amid Epstein fallout](https://longbridge.com/en/news/277812779.md)
- [08:03 ETDecentralized Clinical Trial Validates Novel "Fasting Mimetic" Formulation for Cardiometabolic Health](https://longbridge.com/en/news/277468910.md)